Interferon-λ4 is a cell-autonomous type III interferon associated with pre-treatment hepatitis C virus burden.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Virology

• Publication date

  2015-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.virol.2014.12.020PMID 25577150PMCID PMC4494652
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interferon-stimulated genes: a complex web of host defenses.

  2014cited by this paper
• Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness.

  2014cited by this paper
• IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction

  2013cited by this paper
• IFNL3 (IL28B) favorable genotype escapes hepatitis C virus-induced microRNAs and mRNA decay

  2013cited by this paper
• A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

  2013cited by this paper
• Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses

  2013cited by this paper
• Interferon-λ4 (IFNL4) Transcript Expression in Human Liver Tissue Samples

  2013cited by this paper
• Global control of hepatitis C: where challenge meets opportunity

  2013cited by this paper
• IL‐29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection

  2012cited by this paper
• Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C.

  2011cited by this paper
• Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors.

  2011cited by this paper
• Interferon-stimulated genes and their antiviral effector functions

  2011cited by this paper
• Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C.

  2010cited by this paper
• cPLA2 Regulates the Expression of Type I Interferons and Intracellular Immunity to Chlamydia trachomatis*

  2010cited by this paper
• IL28B genotype is associated with differential expression of intrahepatic interferon‐stimulated genes in patients with chronic hepatitis C

  2010cited by this paper
• IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy

  2009cited by this paper
• Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection.

  2009cited by this paper
• Measuring HCV infectivity produced in cell culture and in vivo.

  2009cited by this paper
• Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

  2009cited by this paper
• Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

  2009cited by this paper
• Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

  2009cited by this paper
• Interferon signaling and treatment outcome in chronic hepatitis C

  2008cited by this paper
• IFN-Lambda (IFN-λ) Is Expressed in a Tissue-Dependent Fashion and Primarily Acts on Epithelial Cells In Vivo

  2008cited by this paper
• Why Do We Still Have a Maternally Inherited Mitochondrial DNA ? Insights from Evolutionary Medicine

  2007cited by this paper
• Cell culture and infection system for hepatitis C virus

  2006cited by this paper
• Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.

  2006cited by this paper
• Interferons α and λ Inhibit Hepatitis C Virus Replication With Distinct Signal Transduction and Gene Regulation Kinetics

  2006cited by this paper
• Lambda Interferon Inhibits Hepatitis B and C Virus Replication

  2005cited by this paper
• IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex.

  2003cited by this paper
• IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex

  2003cited by this paper
• Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication

  2002cited by this paper
• IL-28, IL-29 and their class II cytokine receptor IL-28R

  2002cited by this paper
• Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient *

  2001cited by this paper

• Structural studies of the IFNλ4 receptor complex using cryoEM enabled by protein engineering

  2025cites this paper
• IFN-λ3 is induced by Leishmania donovani and can inhibit parasite growth in cell line models but not in the mouse model, while it shows a significant association with leishmaniasis in humans

  2024cites this paper
• Interferon lambda 4 is a gut antimicrobial protein

  2024cites this paper
• Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses

  2021cites this paper
• The Role of Ku70 as a Cytosolic DNA Sensor in Innate Immunity and Beyond

  2021cites this paper
• Monocytes differentiated into macrophages and dendritic cells in the presence of human IFN‐λ3 or IFN‐λ4 show distinct phenotypes

  2020cites this paper
• Interferon Response in Hepatitis C Virus-Infected Hepatocytes: Issues to Consider in the Era of Direct-Acting Antivirals

  2020cites this paper
• Innate Immunity in Hepatitis C Virus Infection.

  2020cites this paper
• Macrophage Coordination of the Interferon Lambda Immune Response

  2019cites this paper
• The IFN-λ4 Conundrum: When a Good Interferon Goes Bad

  2019cites this paper
• Genetics of the Human Interferon Lambda Region

  2019cites this paper
• siRNA containing a unique 5-nucleotide motif acts as a quencher of IFI16-mediated innate immune response

  2019cites this paper
• Interferon-λ3/4 genetic variants and interferon-λ3 serum levels are biomarkers of lupus nephritis and disease activity in Taiwanese

  2018cites this paper
• A polymorphic residue that attenuates the antiviral potential of interferon lambda 4 in hominid lineages

  2018cites this paper
• Long Non-Coding RNA-Mediated Regulation of the Interferon Response: A New Perspective on a Familiar Theme

  2018cites this paper
• STING is an essential mediator of the Ku70-mediated production of IFN-λ1 in response to exogenous DNA

  2017cites this paper
• IFN-λ3, not IFN-λ4, likely mediates IFNL3–IFNL4 haplotype–dependent hepatic inflammation and fibrosis

  2017cites this paper
• IFN-λ4 Attenuates Antiviral Responses by Enhancing Negative Regulation of IFN Signaling

  2017cites this paper
• IFN-λ4 potently blocks IFN-α signalling by ISG15 and USP18 in hepatitis C virus infection

  2017cites this paper
• Evaluation of HTLV‐1 HBZ and proviral load, together with host IFN λ3, in pathogenesis of HAM/TSP

  2017cites this paper
• Gene–disease association with human IFNL locus polymorphisms extends beyond hepatitis C virus infections

  2016cites this paper
• Interferon lambda 4 expression is suppressed by the host during viral infection

  2016influential citation
• Roles for Transcription Factors Sp1, NF-κB, IRF3, and IRF7 in Expression of the Human IFNL4 Gene

  2016cites this paper
• IFN-lambda therapy: current status and future perspectives.

  2016cites this paper
• Comparative Functional Analysis of 12 Mammalian IFN-λ4 Orthologs

  2016cites this paper
• IFN-λ: A New Inducer of Local Immunity against Cancer and Infections

  2016cites this paper
• Altered effector functions of NK cells in chronic hepatitis C are associated with IFNL3 polymorphism

  2015cites this paper
• Interferon Response in Hepatitis C Virus (HCV) Infection: Lessons from Cell Culture Systems of HCV Infection

  2015cites this paper
• Immunopathogenesis of Hepatitis C Virus Infection.

  2015cites this paper
• Expression of Interferon Lambda 4 Is Associated with Reduced Proliferation and Increased Cell Death in Human Hepatic Cells

  2015cites this paper
• IFNL3 mRNA structure is remodeled by a functional non-coding polymorphism associated with hepatitis C virus clearance

  2015cites this paper
• Insights into antiviral innate immunity revealed by studying hepatitis C virus.

  2015cites this paper
• IFN-λ 3, not IFN-λ 4, likely mediates IFNL3-IFNL4 haplotype- IFN-3, not IFN-4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis dependent hepatic inflammation and fibrosis

  year unknowncites this paper